Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- New ADRs of Allopurinol, Hydroxycarbamide Reported
April 7, 2003
- Nidek, Otsuka to Comarket Toyama's New Quinolone Eye Drop
April 7, 2003
- 10 Advanced Medical Technologies Approved
April 7, 2003
- Ushioda Sangokudo Acquires Kuraya Sanseido's North Kanto Business
April 7, 2003
- Test Conditions Announced for 24th Quality Reevaluation
April 7, 2003
- BUSINESS NEWS IN BRIEF
April 7, 2003
- REGULATORY NEWS IN BRIEF
April 7, 2003
- Social Sec. Premiums to Account for 13.5% of Household Costs in 2025
April 7, 2003
- WEBSITE NEWS
April 7, 2003
- Gov't Draft Plan Recommends Regulatory Reform in Nursing Care Field
April 7, 2003
- CDFS Recommends Designation of Bio-derived Products
April 7, 2003
- Janssen's Sales Top \50 Bil., 4th Double-Digit Growth in 4 Years: President Sekiguchi
April 7, 2003
- Patient Meal Market to Grow 25% by 2007: Report
April 7, 2003
- PRESS SEMINAR
April 7, 2003
- Otsuka Licenses Dry Powder Inhaler from Innovata Biomed
April 7, 2003
- 10% Elderly Copayment Puts Brake on Patient Visits: CareNet Survey
April 7, 2003
- Number of Drugstores Up 34% to 14,673 in 2002: METI Statistics
April 7, 2003
- Generics Will Cut Mevalotin Sales "No More than 10%" Sankyo
April 7, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 7, 2003
- 290 Reclassified Quasi-drugs Had Sales of \105 Bil. in 10 Months
April 7, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…